Invesco Ltd. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26,345
-9.6%
10,094
-24.5%
0.00%
Q1 2023$29,158
-76.5%
13,375
-6.9%
0.00%
Q1 2022$124,000
-33.3%
14,370
+10.6%
0.00%
Q4 2021$186,000
-98.9%
12,991
-98.3%
0.00%
-100.0%
Q3 2021$16,599,000
+10678.6%
755,195
+6478.4%
0.00%
Q2 2021$154,00011,4800.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders